CLINICAL_TRIALS
trial_result
· 2016-04-12
Clinical Trial Update: Effect of Panitumumab on the Pharmacokinetics of Irinotecan [Phase 1]
Summary
Phase 1 trial evaluating whether panitumumab alters the pharmacokinetics of irinotecan in metastatic colorectal cancer; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-04-12